Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Russell-Jones D, Cuddihy RM, Hanefeld M, Kumar A, Gonzalez JG, Chan M, et al
If you are traveling with tirzepatide specifically, check our guide on how to travel with tirzepatide for storage and temperature management tips
Consult an expert for options that suit your health and objectives
Statistically significant reductions in all-cause mortality, progression to myelofibrosis, and venous thromboembolism (VTE) occurred among patients with polycythemia vera (PV) who received glucagon-like peptide-1 receptor agonists (GLP-1a), according to data from a propensity-matched analysis presented at the Additionally, the use of GLP-1a conferred a low incidence of hospitalization, intensive care unit (ICU) admission, acute kidney injury (AKI), and ischemic stroke or transient ischemic attack (TIA) in this patient population
US$ 21.20
US$ 26.96
US$ 23.42
